Global Acellular Dermal Matrices Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Regenerative Medicine

1
Global Acellular Dermal Matrices Market Is
Estimated To Witness High Growth Owing To
Increasing Adoption of Regenerative Medicine
The global Acellular Dermal Matrices Market is
estimated to be valued at US 7,014.0 million in
2021 and is expected to exhibit a CAGR of 12.1
over the forecast period 2022-2030, as
highlighted in a new report published by
Coherent Market Insights. Market Overview
Acellular dermal matrices (ADMs) are biologic
implants used in regenerative medicine and tissue
engineering. They are derived from human or
animal tissues by processing and removing the
cellular components while preserving the
extracellular matrix (ECM). These matrices serve
as a scaffold for the regeneration of damaged
tissues and provide a supportive environment for
cell attachment, proliferation, and migration.
The use of ADMs in reconstructive surgeries has
gained significant traction in recent years due
to their numerous advantages. They offer several
benefits over traditional grafting techniques,
including reduced risk of infection, improved
wound healing, minimal scarring, and better
aesthetic outcomes. ADMs also have a wide range
of applications, including breast reconstruction,
wound healing, hernia repair, diabetic foot
ulcers, and periodontal regeneration. Market key
trends One key trend in the Acellular Dermal
Matrices Market is the increasing adoption of
regenerative medicine. Regenerative medicine
aims to restore the structure and function of
damaged or diseased
2
tissues using biomaterials, growth factors, stem
cells, and tissue engineering techniques. ADMs
play a crucial role in regenerative medicine as
they provide the necessary scaffolds and signals
for tissue regeneration. The growing prevalence
of chronic diseases, such as diabetes and
cardiovascular disorders, has led to an increased
demand for regenerative medicine products,
driving the market for ADMs. For example, ADMs
are being extensively used in the treatment of
diabetic foot ulcers. According to the
International Diabetes Federation, around 415
million people are living with diabetes
worldwide, and approximately 10-15 of these
individuals will develop a diabetic foot ulcer in
their lifetime. ADMs help in the closure of
chronic wounds and promote healing, thereby
reducing the risk of amputations in diabetic
patients. PEST Analysis Political Governments
across the globe are increasingly focusing on
promoting regenerative medicine and tissue
engineering research. This includes funding
research projects, establishing regulatory
frameworks, and encouraging collaborations
between academia, industry, and healthcare
institutions. Economic The Acellular Dermal
Matrices Market is driven by various economic
factors, including the rising healthcare
expenditure, increasing disposable income, and
the growing demand for advanced medical
technologies. Social The aging population and
the increasing prevalence of chronic diseases
have led to a higher demand for tissue
regeneration products. Additionally, the growing
awareness about the benefits of regenerative
medicine among patients and healthcare
professionals is driving market growth.
Technological Advancements in tissue
engineering and biomaterials technology have led
to the development of more effective and
biocompatible ADMs. Novel manufacturing
techniques, such as decellularization and
cross-linking, have improved the mechanical
properties, stability, and efficacy of these
matrices. Key Takeaways - The global
Acellular Dermal Matrices Market is expected to
witness high growth, exhibiting a CAGR of 12.1
over the forecast period. This growth is driven
by the increasing adoption of regenerative
medicine and tissue engineering techniques. -
North America is expected to be the
fastest-growing and dominating region in the
Acellular Dermal Matrices Market. The region has
a well-established healthcare infrastructure,
favorable reimbursement policies, and a high
prevalence of chronic diseases. - Key players
operating in the global Acellular Dermal Matrices
Market include Integra LifeSciences Corporation,
AbbVie Inc., Johnson Johnson, HansBioMed, and
Becton, Dickinson and Company. These players are
focusing on strategic collaborations, product
innovations, and mergers and acquisitions to
strengthen their market presence. In
conclusion, the global Acellular Dermal Matrices
Market is witnessing significant growth due to
the increasing adoption of regenerative medicine
and the numerous advantages offered by ADMs. The
market is expected to continue growing at a high
rate over the forecast period, driven by the
3
rising prevalence of chronic diseases and
advancements in tissue engineering technology.
North America is expected to be the
fastest-growing region, and key players are
implementing various strategies to maintain their
market position.